NCT04802603: Dose-Escalated Spine SBRT for Localized Metastasis to the Spinal Column

NCT04802603
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: 
Exclusions: Patients with greater than 50% loss of vertebral body height or spinal instability to due pathologic compression fracture
https://ClinicalTrials.gov/show/NCT04802603

Comments are closed.

Up ↑